Claims Associated With Birth Control – Yaz, Yasmin, and Ocella
September 4, 2009—New York. Seeger Weiss LLP is investigating injury claims associated with the popular birth control drugs Yaz, Yasmin, and Ocella. Recent reports suggest that these prescription medications could be putting millions of young women at risk of serious side effects, including stroke, heart attack, blood clots, deep vein thrombosis, pulmonary embolism, and even death. A recent study published by the British Medical Journal demonstrated that birth control products containing the active ingredient contained in Yaz, Yasmin, and Ocella—drospirenone–carried a risk of blood clots nearly double that of other birth control medications. Other reports have associated drospirenone with an increased risk of gall bladder disease, resulting in removal.
Yaz Manufacturers Warned By FDA
YAZ and Yasmin are manufactured by Bayer HealthCare Pharmaceuticals, Inc. Ocella is the generic equivalent of Yasmin, manufactured by Barr Laboratories. Bayer has previously received warnings from the Food & Drug Administration (FDA) for advertisements that overstated the benefits of Yaz and which minimized the potential safety risks associated with the drug. As a part of a subsequent agreement with the FDA and attorneys general in 27 states, Bayer began running a new ad campaign in February 2009 to correct the information conveyed by deceptive Yaz commercials.
If you or a family member have used the prescription contraceptives Yaz, Yasmin, or Ocella, and noticed any of these adverse side effects, you should contact a physician immediately. If you feel that you may need legal representation in this matter or are interested in more information on Yaz litigation, please contact us, toll-free and an experienced attorney with Seeger Weiss LLP will assist you in evaluating your case concerning Yaz, Yasmin, or Ocella. Attorney consultations incur no obligation on your part and all initial consultations are free of charge. Seeger Weiss LLP has office locations in New York, New Jersey, Philadelphia, and California.
1 (888) 584-0411Free Case Evaluation
Seeger Weiss LLP is investigating allegations by the Justice Department that U.S. airlines may have unlawfully colluded to control the number of available seats on flights in order to drive up ticket [...]July 2, 2015 By: Seeger Weiss LLP read more
Results from a recent data mining study conducted at Houston Methodist and Stanford University, California, showed that patients using proton pump inhibitors face a significantly higher risk for suffering a heart attack [...]June 15, 2015 By: Seeger Weiss LLP read more
Experts at The University of Pittsburgh Medical Center and Ohio State University have called for more research into possible health risks of a potentially toxic chemical, gadolinium, remaining in brain tissue of [...]June 12, 2015 By: Seeger Weiss LLP read more